Table 1.
N | 1758 |
Age (yrs) | 58.8 (51.0, 67.8) |
Body mass index () | 30.0 (26.0, 35.5) |
Male, n (%) | 1245 (70.8) |
Race – African American, n (%) | 588 (34.0) |
White, n (%) | 1055 (61.0) |
Other, n (%) | 86 (5.0) |
Ejection fraction (%) | 24.6 (20.1, 30.1) |
Ischemic etiology, n (%) | 853 (48.5) |
Hypertension, n (%) | 1030 (59.0) |
Diabetes, n (%) | 556 (31.6) |
Therapies | |
ACE inhibitors, n (%) | 1313 (74.7) |
ARB, n (%) | 413 (23.5) |
Beta blocker, n (%) | 1668 (94.9) |
Digoxin, n (%) | 781 (44.4) |
Aldosterone antagonist, n (%) | 788 (44.8) |
Biventricular pacemaker, n (%) | 290 (16.5) |
ICD, n (%) | 687 (39.1) |
Systolic blood pressure (mmHg) | 110.0 (100.0, 126.0) |
Heart rate (bpm) | 70.5 (63.0, 79.0) |
Values expressed as medians and interquartile ranges or number and percent. ACE – angiotensin converting enzyme, ARB – angiotensin II receptor blocker, bpm – beats per minute, ICD – implantable cardioverter defibrillator